Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5551-5560 of 11918

Edit search filters
  1. CEUS For Blunt Abdominal Trauma In Children

    Rochester, MN

  2. A Study Of Pirtobrutinib In Participants With Immune Thrombocytopenia

    Rochester, MN

  3. Chronic Nausea And Vomiting In Patients With Normal Gastric Emptying Using The Enterra® Therapy System

    Scottsdale/Phoenix, AZ

  4. A Phase 2/3 Study Of Brepocitinib In Adults With Lichen Planopilaris

    Scottsdale/Phoenix, AZ

  5. Regulation of Muscle Protein Phenotype in Humans with Obesity

  6. A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Participants With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments

    Rochester, MN

  7. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. HEADLIGHT: Hypofractionated Proton Therapy For Head And Neck Cancers

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  9. A Study To Evaluate KIN-2787 In Participants With BRAF And/or NRAS Mutation Positive Solid Tumors

    Jacksonville, FL, Rochester, MN

  10. RESPONDER-HF Trial

    Rochester, MN

.

Mayo Clinic Footer